Chargement en cours...
MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia
Loss of miR-15/16 is the most common genetic lesion in chronic lymphocytic leukemia (CLL), promoting overexpression of BCL2, which factors in leukemia pathogenesis. Indeed, an inhibitor of Bcl2, venetoclcax, is highly active in the treatment of patients with CLL. However, single-agent venetoclcax fa...
Enregistré dans:
| Publié dans: | Proc Natl Acad Sci U S A |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
National Academy of Sciences
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635897/ https://ncbi.nlm.nih.gov/pubmed/28923920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1708264114 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|